[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336483-105":59,"doc-detail-336483-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","therapeutic-targeting-of-voltage-gated-sodium-channel-nav17-for-cancer-metastasis-review","Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis - review","","This review examines expression and function of the voltage-gated sodium channel subtype NaV1.7 across multiple cancers and links it to metastasis-driving cellular behaviors, including proliferation, migration, and invasiveness. It summarizes NaV1.7 structural characteristics, drug binding sites, and inhibitors, addressing suggested pathways such as PKA and EGF/EGFR-ERK1/2. The synthesis discusses how NaV1.7 activity may elevate MACC1 and NHE-1 via p38 MAPK, HGF/c-MET, and c-Jun, promoting extracellular matrix protease secretion (e.g., MMPs) and influencing Rho GTPases, supporting NaV1.7 as a therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/therapeutic-targeting-of-voltage-gated-sodium-channel-nav17-for-cancer-metastasis-review/336483/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/therapeutic-targeting-of-voltage-gated-sodium-channel-nav17-for-cancer-metastasis-review/336483.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does NaV1.7 play in cancer metastasis according to this review?","Question",{"text":112,"@type":113},"The review connects NaV1.7 expression and activity to metastasis-related functions such as proliferation, migration, and invasiveness.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which signaling pathways are discussed as potentially linked to NaV1.7-mediated cancer progression?",{"text":117,"@type":113},"It highlights suggested connections to pathways including PKA and EGF/EGFR-ERK1/2, and a cascade involving p38 MAPK, HGF/c-MET signaling, and c-Jun.",{"name":119,"@type":110,"acceptedAnswer":120},"How does targeting NaV1.7 with inhibitors relate to therapeutic potential?",{"text":121,"@type":113},"The review reports that inhibitors can reduce cancer cell migration, invasion, and tumor growth, supporting NaV1.7 as a promising pharmacological target and an avenue for novel therapeutics.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336483,1790171305,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","TYPE Review  \nPUBLISHED 09 July 2024  \nDOI 10.3389/fphar.2024.1416705  \nOPEN ACCESS  \nEDITED BY  \nLuigi Catacuzzeno,  \nUniversity of Perugia, Italy  \nREVIEWED BY  \nSébastien Roger, Université de Tours, France Hai Minh Nguyen,  \nUniversity of California, Davis, United States  \n*CORRESPONDENCE  \nSadanandan E. Velu,  [svelu@uab.edu](svelu@uab.edu)  \nRECEIVED 12 April 2024  \nACCEPTED 12 June 2024  \nPUBLISHED 09 July 2024  \nCITATION  \nPukkanasut P, Jaskula-Sztul R, Gomora JC and Velu SE (2024), Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis.  \nFront. Pharmacol. 15:1416705 .  \ndoi: 10.3389/fphar.2024.1416705  \nCOPYRIGHT  \n© 2024 Pukkanasut, Jaskula-Sztul, Gomora and Velu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTherapeutic targeting of voltage-gated sodium channel NaV 1.7 for cancer metastasis  \nPiyasuda Pukkanasut 1, Renata Jaskula-Sztul 2,3, Juan Carlos Gomora 4 and Sadanandan E. Velu 1,3*  \n1Department of Chemistry, The University of Alabama at Birmingham, Birmingham, AL, United States, 2Department of Surgery, The University of Alabama at Birmingham, Birmingham, AL, United States, 3O’ Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL, United States, 4Departamento de Neuropatología Molecular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico  \nThis review focuses on the expression and function of voltage-gated sodium channel subtype NaV1.7 in various cancers and explores its impact on the metastasis driving cell functions such as proliferation, migration, and invasiveness. An overview of its structural characteristics, drug binding sites, inhibitors and their likely mechanisms of action are presented. Despite the lack of clarity on the precise mechanism by which NaV1.7 contributes to cancer progression and metastasis; many studies have suggested a connection between NaV1.7 and proteins involved in multiple signaling pathways such as PKA and EGF/EGFR-ERK1/2 . Moreover, the functional activity of NaV1.7 appears to elevate the expression levels of MACC1 and NHE-1, which are controlled by p38 MAPK activity, HGF/c-MET signaling and c-Jun activity. This cascade potentially enhances the secretion of extracellular matrix proteases, such as MMPs which play critical roles in cell migration and invasion activities. Furthermore, the NaV1.7 activity may indirectly upregulate Rho GTPases Rac activity, which is critical for cytoskeleton reorganization, cell adhesion, and actin polymerization. The relationship between NaV1.7 and cancer progression has prompted researchers to investigate the therapeutic potential of targeting NaV1.7 using inhibitors. The positive outcome of such studies resulted in the discovery of several inhibitors with the ability to reduce cancer cell migration, invasion, and tumor growth underscoring the signiﬁcance of NaV1.7 as a promising pharmacological target for attenuating cancer cell proliferation and metastasis. The research ﬁndings summarized in this review suggest that the regulation of NaV1.7 expression and function by small molecules and/or by genetic engineering is a viable approach to discover novel therapeutics for the prevention and treatment of metastasis of cancers with elevated NaV1.7 expression.  \nKEYWORDS  \ncancer, metastasis, voltage-gated sodium channel, Nav1.7, therapeutic targeting, cell invasion, cell migration, cell viability  \n1 Introduction  \nAccording to 2023 statistics provided by American Cancer Society, cancer is the second leading cause of death in the US. The survival r","cbCaidxGYbw08gVx","https://ap.wps.com/l/cbCaidxGYbw08gVx","pdf",3188818,21,"English","# 1 Introduction\n## Metastasis overview and invasion-metastasis cascade\n## Current treatment approaches and limitations","[{\"question\":\"What role does NaV1.7 play in cancer metastasis according to this review?\",\"answer\":\"The review connects NaV1.7 expression and activity to metastasis-related functions such as proliferation, migration, and invasiveness.\"},{\"question\":\"Which signaling pathways are discussed as potentially linked to NaV1.7-mediated cancer progression?\",\"answer\":\"It highlights suggested connections to pathways including PKA and EGF/EGFR-ERK1/2, and a cascade involving p38 MAPK, HGF/c-MET signaling, and c-Jun.\"},{\"question\":\"How does targeting NaV1.7 with inhibitors relate to therapeutic potential?\",\"answer\":\"The review reports that inhibitors can reduce cancer cell migration, invasion, and tumor growth, supporting NaV1.7 as a promising pharmacological target and an avenue for novel therapeutics.\"}]","Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis - review | PDF",1790015284,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c29c30f148689e04f8d2305b57624a14.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b1c5595c1ded8f507ef10e70a1718c9.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d335bea6e601c10ba428186af25b43ab.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a6259d978004730f3a66c5ba10b9bf5.webp",980,1385]